Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IgGFc-binding protein and MUC2 mucin produced by colonic goblet-like cells spatially interact non-covalently and regulate wound healing. | Front Immunol | 2023 | 37359538 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Live-cell imaging of chromatin contacts opens a new window into chromatin dynamics. | Epigenetics Chromatin | 2023 | 37349773 | PubTator, text mining | PubMed |
| Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma. | Neurosci Bull | 2023 | 37347365 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing. | Cancers (Basel) | 2023 | 37345150 | PubTator, text mining | PubMed |
| Galectin-3 and Epithelial MUC1 Mucin-Interactions Supporting Cancer Development. | Cancers (Basel) | 2023 | 37345016 | PubTator, text mining | PubMed |
| Live cell imaging of DNA and RNA with fluorescent signal amplification and background reduction techniques. | Front Cell Dev Biol | 2023 | 37342234 | PubTator, text mining | PubMed |
| Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation. | Int J Biol Sci | 2023 | 37324940 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer. | Front Pharmacol | 2023 | 37324492 | PubTator, text mining | PubMed |
| Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence. | Transl Lung Cancer Res | 2023 | 37323170 | PubTator, text mining | PubMed |
| Deciphering Protein O-GalNAcylation: Method Development and Disease Implication. | ACS Omega | 2023 | 37305274 | PubTator, text mining | PubMed |
| Progress on diagnostic and prognostic markers of pancreatic cancer. | Oncol Res | 2023 | 37304241 | PubTator, text mining | PubMed |
| Prenatal maternal stress is associated with site-specific and age acceleration changes in maternal and newborn DNA methylation. | Epigenetics | 2023 | 37300821 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to Antibody-Drug Conjugates. | Int J Mol Sci | 2023 | 37298631 | PubTator, text mining | PubMed |
| The Regulated Secretion and Models of Intracellular Transport: The Goblet Cell as an Example. | Int J Mol Sci | 2023 | 37298509 | PubTator, text mining | PubMed |
| Mucin 4 is a cellular biomarker of necrotizing bronchiolitis in influenza A virus infection. | Microbes Infect | 2023 | 37295769 | PubTator, text mining | PubMed |
| IL-10/IL-6 ratio from nasal & oral swab samples, acts as an inflammatory indicator for COVID-19 patients infected with the delta variant. | Heliyon | 2023 | 37292329 | PubTator, text mining | PubMed |
| Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. | J Transl Med | 2023 | 37291585 | PubTator, text mining | PubMed |
| Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals. | Sci Rep | 2023 | 37286718 | PubTator, text mining | PubMed |
| Cancer immune exclusion: breaking the barricade for a successful immunotherapy. | Front Oncol | 2023 | 37284199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=25